Experimental therapeutics for refractory obsessive-compulsive disorder: Translational approaches and new somatic developments

Heather A. Berlin, Holly Hamilton, Eric Hollander

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Significant advances over the past 20 years in our understanding of the phenomenology and pathophysiology of obsessive-compulsive disorder, made in part from structural and functional neuroimaging and genetics research, can guide treatments that target brain regions, circuits, and neurotransmitter systems specific to obsessive-compulsive disorder, the disruption of which may alleviate obsessive-compulsive disorder symptoms. We discuss here our current understanding of the underlying neurobiology and heritability of obsessive-compulsive disorder and integrate that understanding with a review of the current pharmacological, neurosurgical, and brain stimulation treatments of refractory obsessive-compulsive disorder. Expanding on these studies, we hope that new pharmacological and psychological treatment strategies and research-driven targets for lesioning, stimulation, or other types of focal neuromodulation can be identified that could lead to future research directions. Cross-species translational research and neuroimaging of the physiological and anatomical pathways implicated in the pathophysiology and treatment response in obsessive-compulsive disorder will advance our understanding of the neural basis of obsessive-compulsive disorder and lead to more targeted and effective treatment options.

Original languageEnglish (US)
Pages (from-to)174-203
Number of pages30
JournalMount Sinai Journal of Medicine
Volume75
Issue number3
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Obsessive-Compulsive Disorder
Therapeutics
Pharmacology
Genetic Research
Functional Neuroimaging
Translational Medical Research
Neurobiology
Brain
Neuroimaging
Neurotransmitter Agents
Psychology
Research

Keywords

  • Caudate nucleus
  • Cingulate gyrus
  • Deep brain stimulation
  • Internal capsule
  • Neurosurgery
  • Obsessive-compulsive disorder
  • Prefrontal cortex
  • Serotonin reuptake inhibitors
  • Therapeutics
  • Transcranial magnetic stimulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Experimental therapeutics for refractory obsessive-compulsive disorder : Translational approaches and new somatic developments. / Berlin, Heather A.; Hamilton, Holly; Hollander, Eric.

In: Mount Sinai Journal of Medicine, Vol. 75, No. 3, 06.2008, p. 174-203.

Research output: Contribution to journalArticle

@article{ebec052b65ba459f8db2e87371dd44be,
title = "Experimental therapeutics for refractory obsessive-compulsive disorder: Translational approaches and new somatic developments",
abstract = "Significant advances over the past 20 years in our understanding of the phenomenology and pathophysiology of obsessive-compulsive disorder, made in part from structural and functional neuroimaging and genetics research, can guide treatments that target brain regions, circuits, and neurotransmitter systems specific to obsessive-compulsive disorder, the disruption of which may alleviate obsessive-compulsive disorder symptoms. We discuss here our current understanding of the underlying neurobiology and heritability of obsessive-compulsive disorder and integrate that understanding with a review of the current pharmacological, neurosurgical, and brain stimulation treatments of refractory obsessive-compulsive disorder. Expanding on these studies, we hope that new pharmacological and psychological treatment strategies and research-driven targets for lesioning, stimulation, or other types of focal neuromodulation can be identified that could lead to future research directions. Cross-species translational research and neuroimaging of the physiological and anatomical pathways implicated in the pathophysiology and treatment response in obsessive-compulsive disorder will advance our understanding of the neural basis of obsessive-compulsive disorder and lead to more targeted and effective treatment options.",
keywords = "Caudate nucleus, Cingulate gyrus, Deep brain stimulation, Internal capsule, Neurosurgery, Obsessive-compulsive disorder, Prefrontal cortex, Serotonin reuptake inhibitors, Therapeutics, Transcranial magnetic stimulation",
author = "Berlin, {Heather A.} and Holly Hamilton and Eric Hollander",
year = "2008",
month = "6",
doi = "10.1002/msj.20045",
language = "English (US)",
volume = "75",
pages = "174--203",
journal = "Annals of Global Health",
issn = "0027-2507",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Experimental therapeutics for refractory obsessive-compulsive disorder

T2 - Translational approaches and new somatic developments

AU - Berlin, Heather A.

AU - Hamilton, Holly

AU - Hollander, Eric

PY - 2008/6

Y1 - 2008/6

N2 - Significant advances over the past 20 years in our understanding of the phenomenology and pathophysiology of obsessive-compulsive disorder, made in part from structural and functional neuroimaging and genetics research, can guide treatments that target brain regions, circuits, and neurotransmitter systems specific to obsessive-compulsive disorder, the disruption of which may alleviate obsessive-compulsive disorder symptoms. We discuss here our current understanding of the underlying neurobiology and heritability of obsessive-compulsive disorder and integrate that understanding with a review of the current pharmacological, neurosurgical, and brain stimulation treatments of refractory obsessive-compulsive disorder. Expanding on these studies, we hope that new pharmacological and psychological treatment strategies and research-driven targets for lesioning, stimulation, or other types of focal neuromodulation can be identified that could lead to future research directions. Cross-species translational research and neuroimaging of the physiological and anatomical pathways implicated in the pathophysiology and treatment response in obsessive-compulsive disorder will advance our understanding of the neural basis of obsessive-compulsive disorder and lead to more targeted and effective treatment options.

AB - Significant advances over the past 20 years in our understanding of the phenomenology and pathophysiology of obsessive-compulsive disorder, made in part from structural and functional neuroimaging and genetics research, can guide treatments that target brain regions, circuits, and neurotransmitter systems specific to obsessive-compulsive disorder, the disruption of which may alleviate obsessive-compulsive disorder symptoms. We discuss here our current understanding of the underlying neurobiology and heritability of obsessive-compulsive disorder and integrate that understanding with a review of the current pharmacological, neurosurgical, and brain stimulation treatments of refractory obsessive-compulsive disorder. Expanding on these studies, we hope that new pharmacological and psychological treatment strategies and research-driven targets for lesioning, stimulation, or other types of focal neuromodulation can be identified that could lead to future research directions. Cross-species translational research and neuroimaging of the physiological and anatomical pathways implicated in the pathophysiology and treatment response in obsessive-compulsive disorder will advance our understanding of the neural basis of obsessive-compulsive disorder and lead to more targeted and effective treatment options.

KW - Caudate nucleus

KW - Cingulate gyrus

KW - Deep brain stimulation

KW - Internal capsule

KW - Neurosurgery

KW - Obsessive-compulsive disorder

KW - Prefrontal cortex

KW - Serotonin reuptake inhibitors

KW - Therapeutics

KW - Transcranial magnetic stimulation

UR - http://www.scopus.com/inward/record.url?scp=55549147907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55549147907&partnerID=8YFLogxK

U2 - 10.1002/msj.20045

DO - 10.1002/msj.20045

M3 - Article

C2 - 18704978

AN - SCOPUS:55549147907

VL - 75

SP - 174

EP - 203

JO - Annals of Global Health

JF - Annals of Global Health

SN - 0027-2507

IS - 3

ER -